K M Mohler

3.1k total citations · 2 hit papers
23 papers, 2.5k citations indexed

About

K M Mohler is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, K M Mohler has authored 23 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in K M Mohler's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Immunotherapy and Immune Responses (5 papers) and Immune Cell Function and Interaction (4 papers). K M Mohler is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Immunotherapy and Immune Responses (5 papers) and Immune Cell Function and Interaction (4 papers). K M Mohler collaborates with scholars based in United States and Canada. K M Mohler's co-authors include Mark Kennedy, Kathleen S. Picha, Victor Fung, Hassan Madani, M B Widmer, Roy A. Black, João S. Silva, K H Grabstein, Philip Morrissey and Steven G. Reed and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

K M Mohler

21 papers receiving 2.4k citations

Hit Papers

Soluble tumor necrosis factor (TNF) receptors are effecti... 1992 2026 2003 2014 1993 1992 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.
    1993 686 citations K M Mohler, Victor Fung et al. The Journal of Immunology profile →
  2. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery
    1992 543 citations Mark Kennedy, Kathleen S. Picha et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K M Mohler United States 15 1.2k 531 528 511 309 23 2.5k
R. B. Nussenblatt United States 23 1.1k 0.9× 387 0.7× 432 0.8× 300 0.6× 493 1.6× 45 2.8k
Wendy F. Davidson United States 34 2.1k 1.7× 303 0.6× 1.1k 2.0× 391 0.8× 235 0.8× 69 3.6k
Richard P. Nordan United States 23 1.7k 1.4× 284 0.5× 873 1.7× 647 1.3× 213 0.7× 39 3.2k
Paula S. Hochman United States 29 2.5k 2.1× 250 0.5× 592 1.1× 580 1.1× 179 0.6× 42 3.4k
Kendall M. Mohler United States 15 1.4k 1.1× 315 0.6× 667 1.3× 555 1.1× 842 2.7× 17 3.2k
Yolande Chvatchko Switzerland 27 1.7k 1.4× 595 1.1× 1.6k 3.0× 390 0.8× 259 0.8× 43 3.4k
P E Lipsky United States 31 2.2k 1.8× 266 0.5× 841 1.6× 455 0.9× 269 0.9× 46 3.6k
Kristine Kikly United States 22 2.1k 1.7× 270 0.5× 1.0k 1.9× 643 1.3× 519 1.7× 32 3.4k
Genevieve Whitty Australia 21 1.4k 1.2× 241 0.5× 757 1.4× 651 1.3× 254 0.8× 35 2.9k
Janet E. Wilson Canada 31 888 0.7× 408 0.8× 1.2k 2.4× 364 0.7× 197 0.6× 67 3.2k

Countries citing papers authored by K M Mohler

Since Specialization
Citations

This map shows the geographic impact of K M Mohler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K M Mohler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K M Mohler more than expected).

Fields of papers citing papers by K M Mohler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K M Mohler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K M Mohler. The network helps show where K M Mohler may publish in the future.

Co-authorship network of co-authors of K M Mohler

This figure shows the co-authorship network connecting the top 25 collaborators of K M Mohler. A scholar is included among the top collaborators of K M Mohler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K M Mohler. K M Mohler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nickerson‐Nutter, Cheryl, Lioudmila Tchistiakova, Nilufer P. Seth, et al.. (2011). Distinct in vitro binding properties of the anti-CD20 small modular immunopharmaceutical 2LM20-4 result in profound and sustained in vivo potency in cynomolgus monkeys. Lara D. Veeken. 50(6). 1033–1044. 6 indexed citations
2.
3.
4.
Barone, D., C. Nilsson, J A Ledbetter, Martha Hayden-Ledbetter, & K M Mohler. (2006). Efficacy of SMIP-016, a novel CD37-directed biologic therapy, in human NHL tumor xenograft models. Journal of Clinical Oncology. 24(18_suppl). 2565–2565. 1 indexed citations
5.
6.
Zask, Arie, Ying Gu, J. Donald Albright, et al.. (2003). Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(8). 1487–1490. 26 indexed citations
7.
Schuh, JoAnn C. L., et al.. (2002). Periosteal Hyperostosis (Exostosis) in DBA/1 Male Mice. Toxicologic Pathology. 30(3). 390–393. 2 indexed citations
8.
Moreland, Larry W., R. Pat Bucy, Michael E. Weinblatt, et al.. (2002). Immune Function in Patients with Rheumatoid Arthritis Treated with Etanercept. Clinical Immunology. 103(1). 13–21. 45 indexed citations
9.
Levin, Jeremy I., Frances C. Nelson, Loran M. Killar, et al.. (2002). Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1′ group. Bioorganic & Medicinal Chemistry Letters. 12(8). 1199–1202. 62 indexed citations
10.
Levin, Jeremy I., Frances C. Nelson, John F. DiJoseph, et al.. (2001). The discovery of anthranilic acid-based mmp inhibitors. Part 3: incorporation of basic amines. Bioorganic & Medicinal Chemistry Letters. 11(22). 2975–2978. 30 indexed citations
11.
Smith, Craig A., Terri Smith, Pamela J. Smolak, et al.. (1997). Poxvirus Genomes Encode a Secreted, Soluble Protein That Preferentially Inhibits β Chemokine Activity yet Lacks Sequence Homology to Known Chemokine Receptors. Virology. 236(2). 316–327. 158 indexed citations
12.
Crowe, Paul D., et al.. (1995). A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes.. The Journal of Experimental Medicine. 181(3). 1205–1210. 213 indexed citations
13.
Müllberg, Jürgen, Fiona H. Durie, Mark R. Alderson, et al.. (1995). A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. The Journal of Immunology. 155(11). 5198–5205. 215 indexed citations
14.
Rosenbaum, James T., et al.. (1994). Failure to inhibit endotoxin-induced uveitis with soluble TNF receptors. 6. 73–75. 5 indexed citations
15.
Jacobs, Cindy, M P Beckmann, K M Mohler, et al.. (1993). Pharmacokinetic Parameters and Biodistribution of Soluble Cytokine Receptors. PubMed. 34 Pt B. 123–135. 32 indexed citations
16.
Mohler, K M, et al.. (1993). Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.. The Journal of Immunology. 151(3). 1548–1561. 686 indexed citations breakdown →
17.
Kennedy, Mark, et al.. (1992). Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. The Journal of Immunology. 149(7). 2496–2505. 543 indexed citations breakdown →
18.
Silva, João S., Philip Morrissey, K H Grabstein, et al.. (1992). Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection.. The Journal of Experimental Medicine. 175(1). 169–174. 314 indexed citations
19.
Mohler, K M & L D Butler. (1990). Differential production of IL-2 and IL-4 mRNA in vivo after primary sensitization.. The Journal of Immunology. 145(6). 1734–1739. 52 indexed citations
20.
Streilein, J. Wayne, K M Mohler, & Peter J. Wood. (1987). Mechanisms of neonatal transplantation tolerance.. PubMed. 19(6 Suppl 7). 82–7. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. B. Nussenblatt Breakdown of academic impact, for papers by Wendy F. Davidson Breakdown of academic impact, for papers by Richard P. Nordan Breakdown of academic impact, for papers by Paula S. Hochman Breakdown of academic impact, for papers by Kendall M. Mohler Breakdown of academic impact, for papers by Yolande Chvatchko Breakdown of academic impact, for papers by P E Lipsky Breakdown of academic impact, for papers by Kristine Kikly Breakdown of academic impact, for papers by Genevieve Whitty Breakdown of academic impact, for papers by Janet E. Wilson
Rankless by CCL
2026